We are live on ! Find out more
GSK icon

GSK
GSK

639 hedge funds and large institutions have $13.8B invested in GSK in 2013 Q2 according to their latest regulatory filings, with 639 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more call options, than puts

Call options by funds: $124M | Put options by funds: $87.1M

4.49% more ownership

Funds ownership: 0% → 4.49% (+4.5%)

Holders
639
Holders Change
+639
Holders Change %
–
% of All Funds
20.85%
Holding in Top 10
14
Holding in Top 10 Change
+14
Holding in Top 10 Change %
% of All Funds
0.46%
New
639
Increased
–
Reduced
–
Closed
–
Calls
$124M
Puts
$87.1M
Net Calls
+$37.2M
Net Calls Change
+$37.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CFS
601
Community Financial System
New York
$35K +$35.5K +560 New
SC
602
StellarOne Corp
Virginia
$35K +$35.7K +562 New
BFEC
603
Benjamin F. Edwards & Company
Missouri
$34K +$34.1K +538 New
CA
604
CapWealth Advisors
Tennessee
$34K +$34.1K +538 New
CAW
605
Cornerstone Advisors (Washington)
Washington
$34K +$34.9K +550 New
SFSIG
606
San Francisco Sentry Investment Group
California
$34K +$35K +552 New
ST
607
Spot Trading
Illinois
$33K +$33.1K +522 New
FMT
608
First Mercantile Trust
Tennessee
$33K +$33.9K +534 New
ARMC
609
American Research & Management Company
Massachusetts
$31K +$31.7K +500 New
TRCT
610
Tower Research Capital (TRC)
New York
$28K +$28.4K +448 New
FHB
611
First Hawaiian Bank
Hawaii
$26K +$26.3K +414 New
BOK
612
Bank of Kentucky
Kentucky
$23K +$23.1K +364 New
ATC
613
Adirondack Trust Company
New York
$20K +$20.3K +320 New
CCM
614
Chilton Capital Management
Texas
$20K +$20.3K +320 New
RBC
615
Ronald Blue & Co
Georgia
$20K +$20.7K +326 New
EU
616
Emory University
Georgia
$14K +$14.7K +231 New
HCM
617
Highlander Capital Management
New Jersey
$13.7K +$14K +220 New
FNBSF
618
First National Bank Sioux Falls
South Dakota
$12K +$12.7K +200 New
DBT
619
Dubuque Bank & Trust
Iowa
$11K +$11.5K +181 New
BWM
620
Baystate Wealth Management
Massachusetts
$10K +$9.9K +156 New
AF
621
Arrow Financial
New York
$10K +$10.2K +160 New
AAC
622
Asset Advisors Corp
Georgia
$10K +$10.2K +160 New
SMA
623
Simply Money Advisors
Ohio
$10K +$10.2K +160 New
WF
624
WealthTrust Fairport
Ohio
$10K +$10.6K +167 New
MIM
625
Macroview Investment Management
Maryland
$10K +$10.7K +168 New
22 23 24
25
26

GSK Hedge Fund Activity: Q2 2013 in Review

639 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q2 2013, worth a combined $13.8B.

Buyers outnumbered sellers: 639 funds opened new GSK positions and 0 closed out — a net gain of 639 holders — while 0 added to existing stakes and 0 trimmed.

  • 639 institutional investors held GSK (GSK) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $13.8B of GSK stock for Q2 2013.
  • 639 funds opened new GSK positions in Q2 2013 and 0 closed out, a net change of +639 holders.

Based on aggregated 13F filings for Q2 2013.